Search

The Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) is coming up early next year on January 28-30, 2026 in Las Vegas.   The meeting will bring together the top scientists, innovators, and cross-sector leaders to

The Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) is coming up early next year on January 28-30, 2026 in Las Vegas.   The meeting will bring together the top scientists, innovators, and cross-sector leaders to

Is passion enough for to keep our industry going? Jennifer Leeds (ex-Novartis; one of the microbiologists who had to help shut down Novartis’ infectious disease department) published a new perspective on antibiotic R&D talent drain, sharing

Phaxiam (Lyon, France) is a phage therapy biotech company always looking for motivated talent. Interested? Send them an open application and let them know!

Matt McEnany (U Colorado) and Kevin Outterson (Boston University, Founder and Executive Director of CARB-X) published a new paper on evaluating Germany's new antimicrobial reimbursement reforms. They compare these reforms to delinked pull i

The Westmead Institute for Medical Research is hiring a Senior Research Assistant to assist in developing therapeutic plasmids targeting antimicrobial resistance in bacteria.

The Westmead Institute for Medical Research is hiring a Senior Research Assistant to assist in developing therapeutic plasmids targeting antimicrobial resistance in bacteria.

Ely O. Aboka of the Phage Hunters Training and Research Program in Nairobi, Kenya will host a LinkedIn Live panel discussion on July 31st, 2024 from 9:00 PM EAT on the topic 'Antimicrobial Resistance (AMR) & Phage Therapy.' Panelists includ

The CDC has launched an Antimicrobial Resistance Investment Map (interestingly, they are calling it ‘AR’ now — is this our new acronym for AMR?). The map illustrates the allocation of CDC funds in the US and abroad. Explore funding landscap

The UK government has responded to the Science, Innovation, and Technology Committee's report on the antimicrobial potential of phages, outlining recommendations for assessing the safety and effectiveness of phages in healthcare settings.

The Alfred and Monash University collaboration had explored phage therapy for four patients by February 2024, with patients considered eligible only on compassionate grounds in Australia. The team described the approach as experimental. Alf

Le Temps newspaper in Switzerland featured phage therapy for antimicrobial resistance on its front page.

US Representative Morgan Griffith recently discussed the potential of phage therapy to combat antimicrobial resistance at the April 28, 2023 U.S. House Subcommittee on Oversight and Investigations meeting.

The Ohio State University and IPATH were awarded $175k from the Herbert W. Hoover Foundation to address AMR through phage therapy, with students in OSU’s Science Education Alliance-LAB undergraduate program isolating and characterizing phag

In this podcast, Dr. Jeremy Barr from Monash University and Phage Australia talks about his research on using phages to restore antimicrobial sensitivity in Acinetobacter baumannii.

In this CIDRAP podcast episode, 'Phage Against the Routine', Steffanie Strathdee, Greg Merril, Patrick McGann, and Jason Bennett discuss how infections caused by resistant Acinetobacter impact patients and new treatments.

This MRC-funded project, led by Dr Gwen Knight (LSHTM) and Professor Jodi Lindsay (SGUL), will use mathematical modelling and data analysis to quantify the distributions of resistance in the clinical important bacteria methicillin resistant

In this opinion piece for USA Today, Mallory Smith's mother, Diane Shader Smith, describes her daughter's preventable death from a drug resistant infection, and reflects on the opportunity that currently exists for US Congress to pass the P

The Hull York Medical School is looking for a PhD student to work on an interdisciplinary programme of work supervised by Dr Holly Wilkinson and colleagues, which aims to elucidate the effects of antimicrobial resistant S. aureus on human s

Abul Tarafder (University of Oxford) and colleagues published a paper in PNAS showing how the phage Pf4 forms a sheath made of liquid crystalline droplets around its host, Pseudomonas aeruginosa, which protects it from antibiotics and more.